140 related articles for article (PubMed ID: 32929120)
1. UQCRH downregulation promotes Warburg effect in renal cell carcinoma cells.
Luo Y; Medina Bengtsson L; Wang X; Huang T; Liu G; Murphy S; Wang C; Koren J; Schafer Z; Lu X
Sci Rep; 2020 Sep; 10(1):15021. PubMed ID: 32929120
[TBL] [Abstract][Full Text] [Related]
2. Genome-wide analysis of DNA methylation identifies the apoptosis-related gene UQCRH as a tumor suppressor in renal cancer.
Miyakuni K; Nishida J; Koinuma D; Nagae G; Aburatani H; Miyazono K; Ehata S
Mol Oncol; 2022 Feb; 16(3):732-749. PubMed ID: 34133843
[TBL] [Abstract][Full Text] [Related]
3. Downregulation of CLDN7 due to promoter hypermethylation is associated with human clear cell renal cell carcinoma progression and poor prognosis.
Li Y; Gong Y; Ning X; Peng D; Liu L; He S; Gong K; Zhang C; Li X; Zhou L
J Exp Clin Cancer Res; 2018 Nov; 37(1):276. PubMed ID: 30428910
[TBL] [Abstract][Full Text] [Related]
4. HSP60 silencing promotes Warburg-like phenotypes and switches the mitochondrial function from ATP production to biosynthesis in ccRCC cells.
Teng R; Liu Z; Tang H; Zhang W; Chen Y; Xu R; Chen L; Song J; Liu X; Deng H
Redox Biol; 2019 Jun; 24():101218. PubMed ID: 31112866
[TBL] [Abstract][Full Text] [Related]
5. Systematic expression analysis of the mitochondrial complex III subunits identifies UQCRC1 as biomarker in clear cell renal cell carcinoma.
Ellinger J; Gromes A; Poss M; Brüggemann M; Schmidt D; Ellinger N; Tolkach Y; Dietrich D; Kristiansen G; Müller SC
Oncotarget; 2016 Dec; 7(52):86490-86499. PubMed ID: 27845902
[TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of ubiquinol-cytochrome c reductase hinge protein expression in patients with clear cell renal cell carcinoma.
Liu WS; Liu YD; Fu Q; Zhang WJ; Xu L; Chang Y; Xu JJ
Am J Cancer Res; 2016; 6(4):797-805. PubMed ID: 27186431
[TBL] [Abstract][Full Text] [Related]
7. The mitochondrial hinge protein, UQCRH, is a novel prognostic factor for hepatocellular carcinoma.
Park ER; Kim SB; Lee JS; Kim YH; Lee DH; Cho EH; Park SH; Han CJ; Kim BY; Choi DW; Yoo YD; Yu A; Lee JW; Jang JJ; Park YN; Suh KS; Lee KH
Cancer Med; 2017 Apr; 6(4):749-760. PubMed ID: 28332314
[TBL] [Abstract][Full Text] [Related]
8. CLEC3B is downregulated and inhibits proliferation in clear cell renal cell carcinoma.
Liu J; Liu Z; Liu Q; Li L; Fan X; Wen T; An G
Oncol Rep; 2018 Oct; 40(4):2023-2035. PubMed ID: 30066941
[TBL] [Abstract][Full Text] [Related]
9. Frequent epigenetic suppression of tumor suppressor gene glutathione peroxidase 3 by promoter hypermethylation and its clinical implication in clear cell renal cell carcinoma.
Liu Q; Jin J; Ying J; Sun M; Cui Y; Zhang L; Xu B; Fan Y; Zhang Q
Int J Mol Sci; 2015 May; 16(5):10636-49. PubMed ID: 25970749
[TBL] [Abstract][Full Text] [Related]
10. Knockout of the Complex III subunit Uqcrh causes bioenergetic impairment and cardiac contractile dysfunction.
Spielmann N; Schenkl C; Komlódi T; da Silva-Buttkus P; Heyne E; Rohde J; Amarie OV; Rathkolb B; Gnaiger E; Doenst T; Fuchs H; Gailus-Durner V; de Angelis MH; Szibor M
Mamm Genome; 2023 Jun; 34(2):229-243. PubMed ID: 36565314
[TBL] [Abstract][Full Text] [Related]
11. TOX3 inhibits cancer cell migration and invasion via transcriptional regulation of SNAI1 and SNAI2 in clear cell renal cell carcinoma.
Jiang B; Chen W; Qin H; Diao W; Li B; Cao W; Zhang Z; Qi W; Gao J; Chen M; Zhao X; Guo H
Cancer Lett; 2019 May; 449():76-86. PubMed ID: 30772441
[TBL] [Abstract][Full Text] [Related]
12. Downregulation of microRNA-1274a induces cell apoptosis through regulation of BMPR1B in clear cell renal cell carcinoma.
Yoshino H; Yonezawa T; Yonemori M; Miyamoto K; Sakaguchi T; Sugita S; Osako Y; Tatarano S; Nakagawa M; Enokida H
Oncol Rep; 2018 Jan; 39(1):173-181. PubMed ID: 29192325
[TBL] [Abstract][Full Text] [Related]
13. HOXA6 inhibits cell proliferation and induces apoptosis by suppressing the PI3K/Akt signaling pathway in clear cell renal cell carcinoma.
Wu F; Wu S; Tong H; He W; Gou X
Int J Oncol; 2019 Jun; 54(6):2095-2105. PubMed ID: 31081053
[TBL] [Abstract][Full Text] [Related]
14. DNMT1-maintained hypermethylation of Krüppel-like factor 5 involves in the progression of clear cell renal cell carcinoma.
Fu RJ; He W; Wang XB; Li L; Zhao HB; Liu XY; Pang Z; Chen GQ; Huang L; Zhao KW
Cell Death Dis; 2017 Jul; 8(7):e2952. PubMed ID: 28749461
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-30a-5p Inhibits the Growth of Renal Cell Carcinoma by Modulating GRP78 Expression.
Wang C; Cai L; Liu J; Wang G; Li H; Wang X; Xu W; Ren M; Feng L; Liu P; Zhang C
Cell Physiol Biochem; 2017; 43(6):2405-2419. PubMed ID: 29073630
[TBL] [Abstract][Full Text] [Related]
16. UQCRH gene encoding mitochondrial Hinge protein is interrupted by a translocation in a soft-tissue sarcoma and epigenetically inactivated in some cancer cell lines.
Modena P; Testi MA; Facchinetti F; Mezzanzanica D; Radice MT; Pilotti S; Sozzi G
Oncogene; 2003 Jul; 22(29):4586-93. PubMed ID: 12881716
[TBL] [Abstract][Full Text] [Related]
17. Epigenetic silencing of ASPP1 confers 5-FU resistance in clear cell renal cell carcinoma by preventing p53 activation.
Wang X; Cheng Y; Zhu Y; Li H; Ge W; Wu X; Zhao K; Yuan J; Li Z; Jiang S; Han Z; Jiang Q; Wu Q; Liu T; Zhang C; Yu M; Hu Y
Int J Cancer; 2017 Oct; 141(7):1422-1433. PubMed ID: 28656647
[TBL] [Abstract][Full Text] [Related]
18. [Suppression of NR0B2 gene in Clear Cell Renal Cell Carcinoma Is Associated with Hypermethylation of Its Promoter].
Kudryavtseva AV; Nyushko KM; Zaretsky AR; Shagin DA; Sadritdinova AF; Fedorova MS; Savvateeva MV; Guvatova ZG; Pudova EA; Alekseev BY; Dmitriev AA; Snezhkina AV
Mol Biol (Mosk); 2018; 52(3):482-488. PubMed ID: 29989580
[TBL] [Abstract][Full Text] [Related]
19. Down-regulation of CD74 inhibits growth and invasion in clear cell renal cell carcinoma through HIF-1α pathway.
Ji SQ; Su XL; Cheng WL; Zhang HJ; Zhao YQ; Han ZX
Urol Oncol; 2014 Feb; 32(2):153-61. PubMed ID: 23273913
[TBL] [Abstract][Full Text] [Related]
20. Systematic Expression Analysis of Mitochondrial Complex I Identifies NDUFS1 as a Biomarker in Clear-Cell Renal-Cell Carcinoma.
Ellinger J; Poss M; Brüggemann M; Gromes A; Schmidt D; Ellinger N; Tolkach Y; Dietrich D; Kristiansen G; Müller SC
Clin Genitourin Cancer; 2017 Aug; 15(4):e551-e562. PubMed ID: 28063846
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]